Appears On
Episode Appearances
Maintenance Phase · Oct 10, 2023
Ozempic
“CNN correspondent used as Novo Nordisk spokesperson; ran hour-long segment on fatness in Black communities 'powered by' the pharmaceutical company”
GLP-1 agonist clinical trial design and real-world effectiveness gapsPharmaceutical drug shortage management and compounding pharmacy regulationWeight loss drug access and insurance coverage disparities
View Analysis